| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.804 | 7.270 | 14.663 | 19.609 | 21.597 | 24.963 | 25.155 | 38.607 | 45.479 | 52.584 |
| Total Income - EUR | 5.804 | 7.270 | 14.663 | 19.609 | 21.597 | 24.963 | 25.155 | 38.607 | 45.479 | 52.615 |
| Total Expenses - EUR | 1.626 | 725 | 1.932 | 4.751 | 2.289 | 1.751 | 1.510 | 2.862 | 12.686 | 16.002 |
| Gross Profit/Loss - EUR | 4.179 | 6.545 | 12.731 | 14.858 | 19.308 | 23.212 | 23.645 | 35.744 | 32.793 | 36.612 |
| Net Profit/Loss - EUR | 4.004 | 6.324 | 12.291 | 14.274 | 18.660 | 22.465 | 22.890 | 34.667 | 32.338 | 36.097 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Nadora Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 1.492 | 1.526 | 787 | 1.838 | 1.121 |
| Current Assets | 4.435 | 5.790 | 13.497 | 16.494 | 19.767 | 41.797 | 61.967 | 83.877 | 74.126 | 49.857 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 140 |
| Receivables | 0 | 0 | 285 | 2.978 | 2.581 | 4.403 | 4.953 | 33.564 | 35.595 | 37.694 |
| Cash | 4.435 | 5.790 | 13.212 | 13.516 | 17.186 | 37.395 | 57.015 | 50.313 | 38.530 | 12.023 |
| Shareholders Funds | -2.338 | 4.010 | 12.343 | 14.326 | 18.711 | 40.823 | 62.807 | 34.716 | 63.692 | 36.145 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.788 | 1.800 | 1.154 | 2.171 | 1.057 | 2.472 | 689 | 49.948 | 12.272 | 14.833 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7830 - 7830" | |||||||||
| CAEN Financial Year |
7830
|
|||||||||
Comments - Nadora Intermed Srl